Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP207807.RATpAJDL5AZCmymtWdtniRPN258JytwuBVnJ2geJWMYOk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP207807.RATpAJDL5AZCmymtWdtniRPN258JytwuBVnJ2geJWMYOk130_assertion type Assertion NP207807.RATpAJDL5AZCmymtWdtniRPN258JytwuBVnJ2geJWMYOk130_head.
- NP207807.RATpAJDL5AZCmymtWdtniRPN258JytwuBVnJ2geJWMYOk130_assertion wasGeneratedBy ECO_0000203 NP207807.RATpAJDL5AZCmymtWdtniRPN258JytwuBVnJ2geJWMYOk130_provenance.
- NP207807.RATpAJDL5AZCmymtWdtniRPN258JytwuBVnJ2geJWMYOk130_assertion wasDerivedFrom lhgdn-20090331 NP207807.RATpAJDL5AZCmymtWdtniRPN258JytwuBVnJ2geJWMYOk130_provenance.
- NP207807.RATpAJDL5AZCmymtWdtniRPN258JytwuBVnJ2geJWMYOk130_assertion SIO_000772 15543615 NP207807.RATpAJDL5AZCmymtWdtniRPN258JytwuBVnJ2geJWMYOk130_provenance.
- NP207807.RATpAJDL5AZCmymtWdtniRPN258JytwuBVnJ2geJWMYOk130_assertion evidence source_evidence_literature NP207807.RATpAJDL5AZCmymtWdtniRPN258JytwuBVnJ2geJWMYOk130_provenance.
- NP207807.RATpAJDL5AZCmymtWdtniRPN258JytwuBVnJ2geJWMYOk130_assertion description "[importance of uPAR to define higher risk subgroups of breast cancer patients with micrometastatic disease ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207807.RATpAJDL5AZCmymtWdtniRPN258JytwuBVnJ2geJWMYOk130_provenance.